# CGM for Management of Type 2 Diabetes in Pregnancy

Study · id `cardio:ct-nct06628453` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06628453](<https://clinicaltrials.gov/study/NCT06628453>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06628453

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 564 participants.

## Technical summary

Registry record NCT06628453. Randomized; no masking; primary purpose treatment. Start 2025-04-08 (actual); primary completion 2029-02 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 564 participants (planned count; ClinicalTrials.gov record NCT06628453, source copy `cardio:ctgov-nct06628453-2026-06-29`, retrieved 2026-10-26)
- Started: 2025-04-08 (actual) (ClinicalTrials.gov record NCT06628453, source copy `cardio:ctgov-nct06628453-2026-06-29`, retrieved 2026-10-26)
- Primary completion: 2029-02 (anticipated) (ClinicalTrials.gov record NCT06628453, source copy `cardio:ctgov-nct06628453-2026-06-29`, retrieved 2026-10-26)
- Completion: 2029-07 (anticipated) (ClinicalTrials.gov record NCT06628453, source copy `cardio:ctgov-nct06628453-2026-06-29`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT06628453, source copy `cardio:ctgov-nct06628453-2026-06-29`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06628453-2026-06-29`, retrieved 2026-10-26)

## The registry's words

- Brief title: CGM for Management of Type 2 Diabetes in Pregnancy
- Acronym: CGM2
- Condition: Type 2 Diabetes Mellitus (T2DM)
- Condition: Pregnancy
- Intervention (Device): CGM
- Lead sponsor: University of Alabama at Birmingham
- Lead sponsor class: OTHER
- Collaborator: National Institutes of Health (NIH)
- Collaborator class: NIH
- Collaborator: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- Collaborator class: NIH

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: University of Alabama at Birmingham (`cardio:org-university-of-alabama-at-birmingham`)
- Registry lists this organization as a collaborator: National Institutes of Health (`cardio:nih`)
- Registry lists this organization as a collaborator: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (`cardio:org-eunice-kennedy-shriver-national-institute-of-child-health-7cbc9f`)

## Provenance

Content hash: fd50958ecaf04d69a05cba915228f3136686f6ed2ecc4de7c1fba4b0ed00fb2f
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
